Post-Herpetic Neuralgia

ASPE Post-Herpetic Neuralgia

American Society of Pain Educators Guidelines Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/84586

Contents of this Issue

Navigation

Page 3 of 7

Selecting a Treatment Regimen Post-Herpetic Neuralgia interventions) and, in some cases, early referral for nerve blocks to facilitate rehabilitation (eg, complex regional pain syndrome) Consider nonpharmacologic treatments (eg, physiotherapy, psychological Initiate pregabalin, topical 5% lidocaine or 8% capsaicin treatment Ineffective, partial response or other diagnosis Initiate first-line drug monotherapy (gabapentin or pregabalin) Ineffective or not tolerated Switch to alternate first-line drug monotherapy (gabapentin or pregabalin) Ineffective or not tolerated Consider switch to TCA or SNRI Ineffective or not tolerated Initiate monotherapy with tapentadol or opioid analgesic Partial treatment response Consider adding alternative first-line drug (gabapentin or pregabalin) Partial treatment response Consider switch to TCA or SNRI Partial treatment response or tapentadol there is a risk of Sero- tonin Syndrome." "If the opioid selected is tramadol Consider adding tapentadol or opioid analgesic Ineffective or not tolerated Refer patients to pain specialty clinic for consideration of third-line drugs, interventional treatments and pain rehabilitation programs

Articles in this issue

Archives of this issue

view archives of Post-Herpetic Neuralgia - ASPE Post-Herpetic Neuralgia